Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01504308 · ClinicalTrials.gov registry record · Phase 2
Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids
A Phase 2 study, sponsored by Philips Healthcare.
- Terminated
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT01504308 is a Phase 2 study that was terminated before completion, run by Philips Healthcare. The registered enrollment target is 49 participants.
The verdict
NCT01504308, a Phase 2 study, was terminated before completion, sponsored by Philips Healthcare.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to determine whether treatment with the Philips Sonalleve Magnetic Resonance-guided High Intensity Focused Ultrasound (MR-HIFU) system is effective in the treatment symptomatic uterine leiomyomas (uterine fibroids).
Interventions
- DEVICE Sham treatment
- DEVICE MR-HIFU treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01504308
The ClinicalTrials.gov registry entry for NCT01504308 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Healthcare, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham treatment is the first listed.
NCT01504308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01504308 about?
NCT01504308 is a clinical study titled "Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids". The purpose of this clinical study is to determine whether treatment with the Philips Sonalleve Magnetic Resonance-guided High Intensity Focused Ultrasound (MR-HIFU) system is effective in the treatment symptomatic uterine leiomyomas (uterine fibroids).
What is the current status of trial NCT01504308?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2012-05. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01504308?
The interventions under investigation include: Sham treatment (DEVICE), MR-HIFU treatment (DEVICE).
Who is sponsoring clinical trial NCT01504308?
This trial is sponsored by Philips Healthcare, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.